Kronos Bio

Developer of small molecule based therapeutics for cancer treatment

placeSan Mateo, California, United States calendar_todayFounded 2017 groups97 employees language kronosbio.com

Registered entities

Innovation

18 patent families (8 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace steady. Cited 2,318 times.

YearFilings
20131
20162
20171
20182
20191
20208
20218
20226
20235
20246
20258
20261

Investor mix

20 investors on record; lead investors include Perceptive Advisors, Vida Ventures, Omega Funds, Bellco Capital.

Investor typeCountShare
Venture capital945%
Private equity315%
Other / undisclosed840%
Coming soon